---

Highlights of December 2020

1. Glenmark inks pact with Menarini Group to commercialize their nasal spray in Europe.
2. COVAXX and Aurobindo Pharma Announce COVID-19 Vaccine Partnership.
3. Biological E, CEPI to jointly develop COVID-19 subunit vaccine candidate.
4. Cipla partners with Premier Medical Corporation to launch rapid antigen test kits.
5. Orexo enters license and supply agreement with Accord Healthcare (unit of Intas Pharma).
6. Exelixis In-Licenses Aurigene’s Novel CDK7 Inhibitor and Files Investigational New Drug Application for Phase 1 Clinical Trial in Advanced Solid Tumors.
7. Olympus to boost respiratory portfolio with $340M acquisition of Veran Medical Technologies.
8. Zimmer Biomet picks up chest surgery toolmaker A&E Medical for $250M cash.
9. Novartis snaps up neuro partner Cadent for $210M upfront with promise of up to $560M more.
10. Mereo BioPharma pens $50M Ultragenyx deal for rare bone disease drug.
11. Gedeon Richter buys rights to Janssen contraceptive patch.
12. Alvotech enters biosimilar partnership in China.
13. Ono acquires global rights to Chordia’s lymphoma candidate.
14. ERT and Bioclinica to Merge, creating a global leader in clinical trial endpoint technology.
15. Investcorp acquires Sanos Group.

Highlights at Aagami:

• Aagami to attend JPM week and Biotech Showcase (digital) in January 2021. Partnering portal open and we are currently accepting meetings.
• Aagami is celebrating its 18th Anniversary by offering special pricing to its clients (Offer period Dec 2020 – Feb 2021, please contact us for more details).